Senseonics Shares Gap Up - What You Need to Know

Senseonics Holdings, Inc. (NYSE:SENS) experienced a notable gap up in its share price before the market opened on Thursday. The stock, which had closed at $1.17 the previous day, opened higher at $1.23 and eventually traded at $1.29, with a substantial trading volume of 5,848,861 shares.

Recent Analyst Ratings

Recently, several research firms have provided updates on SENS shares. HC Wainwright maintained a "buy" rating and set a price target of $2.00 on November 15. Meanwhile, StockNews.com has initiated coverage of Senseonics, assigning a "sell" rating to the company's stock.

Current Stock Performance

Despite the recent upward movement, Senseonics shares are down 5.3% overall. The stock's 50-day simple moving average is noted at $0.73, while its 200-day simple moving average stands at $0.48. The firm has a debt-to-equity ratio of 59.17, with a quick ratio of 2.38 and a current ratio of 2.47, indicating its financial health.

Insider Trading Activity

In insider trading news, CFO Frederick T. Sullivan purchased 124,933 shares at an average price of $0.38 on December 12, valued at approximately $47,474.54. This acquisition increases his holdings to 2,478,844 shares, worth around $941,960.72, representing a 5.31% gain in his position. Similarly, CEO Timothy T. Goodnow acquired 315,000 shares on December 10, buying them at an average price of $0.31, totaling $97,650. Following this transaction, he now owns 11,310,355 shares valued at approximately $3,506,210.05, reflecting a 2.86% rise in his stake. Currently, company insiders hold about 3.60% of the total stock.

Institutional Investments

Several institutional investors have recently engaged with Senseonics shares. Notably, Symmetry Partners LLC acquired a new position in the third quarter worth approximately $164,000. Additionally, GSA Capital Partners LLP invested around $117,000 in new shares during the same timeframe. FMR LLC made significant adjustments to its holdings, boosting its stake by 48,267.2% to now possess 168,318 shares, valued at $59,000 after buying an additional 167,970 shares. Furthermore, Geode Capital Management LLC increased its ownership by 3.2%, now holding 5,838,396 shares valued at around $2,042,000. Ridgecrest Wealth Partners LLC also made new investments valued at about $60,000 in the fourth quarter. In total, institutional investors account for approximately 12.36% of the company's shares.

About Senseonics

Senseonics Holdings, Inc. is a medical technology company dedicated to developing and manufacturing continuous glucose monitoring (CGM) systems for diabetes patients. The company offers products like Eversense, Eversense XL, and Eversense E3, which consist of implantable sensors to monitor glucose levels via a subcutaneous method, complemented by a removable, rechargeable smart transmitter and an app designed for real-time monitoring and management of diabetes.

Further Insights

• Five stocks we like better than Senseonics
• Dividend Screener: How to Evaluate Dividend Stocks Before Buying
• Roblox's Big Dip: A Chance to Get in on the Vaunted Gaming Stock?
• Which Wall Street Analysts are the Most Accurate?
• 3 Dividend ETFs to Capitalize on the Slide in Chip Stocks
• What is the S&P/TSX Index?
• Is Chevron Stock Primed for Growth After Profit-Boosting News?

This report aimed to provide a comprehensive update on Senseonics' recent stock activity, covering insights and changes in analyst ratings, as well as insider and institutional investment trends.

Investment Considerations

Before making any investment decisions, it is crucial to assess the current market climate and how Senseonics fits into your investment strategy. While analysts have a "buy" rating on SENS, there are other stocks that might deserve greater consideration based on current economic trends.

Senseonics, Stock, Investment